Regulatory and compliance issues have diverted resources at home health products supplier Invacare (NYSE:IVC) away from “critical priorities” in the company’s business and have resulted in delays of new product introductions and slowed progress on a key globalization initiative. Those issues stem from negotiations with the U.S. Food and Drug Administration over a possible shutdown […]
Home health products supplier Invacare (NYSE:IVC) is still enmeshed in negotiations with the U.S. Food and Drug Administration over a possible shutdown of some wheelchair production at an Elyria, Ohio plant. In December, Invacare announced that the FDA had asked it to enter into a legal agreement that would require the company to suspend “certain” […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Invacare (NYSE:IVC) plans to move production of a line of manual wheelchairs to Mexico from Ohio, as the home health products company is in the midst of negotiating a legal settlement with the FDA over issues with wheelchair production in the Elyria, Ohio, plant. The Cleveland-area company will shift production of its Solara line of […]
Looking at a possible shutdown of a wheelchair manufacturing facility, home health products maker Invacare (NYSE:IVC) has hired a new compliance and regulatory executive. Doug Uelmen has joined the Elyria, Ohio-based Invacare as senior vice president of quality assurance and regulatory affairs. He boasts more than 30 years experience in quality and regulatory roles, with […]
The U.S. Food and Drug Administration has asked home health products maker Invacare (NYSE:IVC) to enter into a legal agreement that would require the company to suspend “certain” wheelchair manufacturing operations. Under the terms of the FDA’s proposal, Invacare would be required to suspend those operations at its Elyria, Ohio factory until the agency determines […]
Home health products manufacturer Invacare (NYSE:IVC) has acquired a negative-pressure wound therapy system to be sold through its rental business for long-term care providers. But the Elyria, Ohio-based company wouldn’t reveal much more than that, such as the deal’s price or the company it acquired the technology from. Invacare revealed the acquisition in its (pdf) […]
As Invacare (NYSE:IVC) grapples with what it calls “slowness” in its markets, the medical equipment supplier illustrated with a recent acquisition one market in which it sees potential: rentals to long-term care providers like nursing homes and assisted-living facilities. The Elyria, Ohio-based company (pdf) announced last week when releasing its third-quarter earnings that it had […]
Home health equipment maker Invacare (NYSE:IVC) is laying off about 50 workers worldwide, citing a difficult economy and declining reimbursements to its customers. The layoffs are primarily hitting office workers and affect less than 1 percent of the Elyria, Ohio-based company’s 6,200 global workers, spokeswoman Lara Mahoney said. Mahoney partially blamed the layoffs on falling […]
J.B. Richey (left) and Malachi Mixon Invacare (NYSE:IVC) founders Malachi Mixon III and J.B. Richey II have made a $5 million donation to Case Western Reserve University that’s aimed at bolstering the university’s innovation initiatives. The gift will go toward the establishment of a Richey-Mixon Building, which would include space for Case’s school of engineering, […]
Home health products maker Invacare (NYSE: IVC) reported that a controversial new Medicare competitive bidding program for durable medical equipment has had “no significant impact” on its business. The Elyria, Ohio-based company said it expects the program to be “neutral” to its 2011 earnings, according to a statement announcing its second-quarter financial performance. The first […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Home health equipment manufacturer Invacare (NYSE: IVC) has added the president and CEO of Cleveland nonprofit BioEnterprise to its board. Baiju Shah will join Elyria, Ohio-based Invacare’s board of directors, according to a company statement. BioEnterprise was started in 2002 to help Northeast Ohio biomedical companies grow their businesses. Prior to BioEnterprise, Shah worked with […]
Home health products maker Invacare (NYSE: IVC) raised some prices earlier this year and may increase more to offset rising freight and commodity costs. CEO Gerry Blouch said the rising costs didn’t affect the company’s first quarter financial results much, but that could change during the rest of the year. Invacare reported adjusted first-quarter net […]
Home health equipment maker Invacare (NYSE:IVC) has hired a chief compliance officer who previously held the role with Endo Pharmaceuticals (NASDAQ:ENDP). Colleen Craven’s role will be to ensure that Invacare is compliant with “relevant laws and regulations regarding the design, manufacture and distribution of medical devices,” according to a statement from the company. Invacare’s regulatory […]
Home health products maker Invacare Corp.'s (NYSE:IVC) fourth-quarter adjusted earnings beat Wall Street analysts' expectations, thanks to organic sales growth and reduced interest expenses.
Cardinal Health (NYSE: CAH), Ohio's largest company by revenues, led the state's health organizations in federal lobbying spending last year at nearly $1.3 million. Cardinal, a pharmaceuticals distributor and medical products supplier, upped its federal lobbying spending by 39 percent over the prior year, publicly filed lobbying reports revealed.
